Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 07 Oct 2026 for Palisade Bio, INC.. Read the official filing
Filing timeline
BuySaleMitchell Lawrence Jones
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
No signal scores available.
Mitchell Lawrence Jones: trading record in brief
All filings by Mitchell Lawrence Jones on record concern Palisade Bio, Inc. Between 6 November 2023 and 6 October 2026, the trades on record add up to 9 filings.
Sales make up the whole of the open-market record (1 sale, €93k). Other entries cover 1 share grant and 7 option exercises. 2026 to date brings no purchases and 1 sale.
The latest filing, published on 7 October 2026, reports an option exercise in Palisade Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mitchell Lawrence Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
2,620,850 sharesCommon StockSEC:0001493152-26-046202:0
1,031,102 shares@ US$1.49Common StockSEC:0001493152-26-046202:1
131,167 sharesCommon StockSEC:0001493152-26-032561:0
51,880 shares@ US$2.05350.038% mcap49.6% of flowCommon StockSEC:0001493152-26-032561:1
8,000 sharesCommon StockSEC:0001493152-26-006833:0
2,735 shares0Common Stock, par value $0.01SEC:0001493152-24-022038:0
304 shares0Common Stock, par value $0.01SEC:0001493152-24-018284:0
4,558 shares0Common Stock, par value $0.01SEC:0001493152-24-005482:0
4,556 shares0Common Stock, par value $0.01SEC:0001493152-23-039935:0
9 of 9 declarations
